Answers are grounded in this paper and cite their sources.
Recent progress in treatment of MCL improves patient outcomes, indicating a shift in prognosis.
Introduction There have been recent major advances in the management and treatment of mantle cell lymphoma (MCL). This uncommon subtype of mature B-cell lymphoma has a heterogeneous clinical course, including a spectrum of indolent and aggressive disease. While historically regarded as an incurable disease with a poor long-term prognosis, recent developments have improved outcomes.
No takes yet. Share an insight, caveat, or question.
Noor et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: